PLXNB1
Basic information
Region (hg38): 3:48403853-48430086
Previous symbols: [ "PLXN5" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PLXNB1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 19 | 13 | 32 | |||
missense | 113 | 11 | 132 | |||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 3 | 3 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 113 | 31 | 21 |
Variants in PLXNB1
This is a list of pathogenic ClinVar variants found in the PLXNB1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-48404496-G-A | not specified | Uncertain significance (Oct 26, 2022) | ||
3-48405718-G-T | PLXNB1-related disorder | Likely benign (Jan 16, 2020) | ||
3-48407039-C-T | not specified | Likely benign (Mar 19, 2024) | ||
3-48407049-G-A | not specified | Uncertain significance (Jan 08, 2024) | ||
3-48409367-T-C | not specified | Uncertain significance (May 24, 2023) | ||
3-48409368-G-C | not specified | Uncertain significance (Nov 08, 2021) | ||
3-48409421-C-G | not specified | Uncertain significance (Sep 22, 2023) | ||
3-48409421-C-T | not specified | Uncertain significance (Dec 15, 2023) | ||
3-48409644-C-T | not specified | Uncertain significance (Jun 09, 2022) | ||
3-48409676-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-48409677-G-A | not specified | Uncertain significance (Jun 14, 2022) | ||
3-48409685-C-T | not specified | Uncertain significance (Oct 03, 2023) | ||
3-48409686-T-C | not specified | Uncertain significance (Dec 21, 2022) | ||
3-48409714-G-A | PLXNB1-related disorder | Benign (Feb 22, 2019) | ||
3-48409966-C-T | not specified | Uncertain significance (Dec 05, 2022) | ||
3-48409972-C-T | not specified | Uncertain significance (Sep 29, 2023) | ||
3-48410020-T-A | not specified | Uncertain significance (Dec 26, 2023) | ||
3-48410040-G-A | PLXNB1-related disorder | Benign (Jul 31, 2019) | ||
3-48410323-C-T | not specified | Uncertain significance (Dec 18, 2023) | ||
3-48410326-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
3-48410353-C-T | not specified | Uncertain significance (Dec 02, 2022) | ||
3-48410881-G-A | PLXNB1-related disorder | Benign/Likely benign (Feb 21, 2019) | ||
3-48410908-C-G | PLXNB1-related disorder | Benign (Jul 31, 2019) | ||
3-48411029-T-G | not specified | Uncertain significance (Oct 05, 2023) | ||
3-48412277-G-A | PLXNB1-related disorder | Benign (Sep 12, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PLXNB1 | protein_coding | protein_coding | ENST00000358536 | 36 | 26334 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000383 | 1.00 | 125695 | 0 | 53 | 125748 | 0.000211 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.23 | 966 | 1.29e+3 | 0.747 | 0.0000830 | 13536 |
Missense in Polyphen | 408 | 625.19 | 0.6526 | 6878 | ||
Synonymous | -0.133 | 549 | 545 | 1.01 | 0.0000355 | 4579 |
Loss of Function | 6.40 | 25 | 90.7 | 0.275 | 0.00000453 | 1008 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000484 | 0.000483 |
Ashkenazi Jewish | 0.000202 | 0.000198 |
East Asian | 0.000230 | 0.000217 |
Finnish | 0.000285 | 0.000277 |
European (Non-Finnish) | 0.000220 | 0.000211 |
Middle Eastern | 0.000230 | 0.000217 |
South Asian | 0.000131 | 0.000131 |
Other | 0.000177 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for SEMA4D. Plays a role in RHOA activation and subsequent changes of the actin cytoskeleton. Plays a role in axon guidance, invasive growth and cell migration. {ECO:0000269|PubMed:12196628, ECO:0000269|PubMed:12198496, ECO:0000269|PubMed:15210733, ECO:0000269|PubMed:19843518, ECO:0000269|PubMed:20877282, ECO:0000269|PubMed:21912513}.;
- Pathway
- Axon guidance - Homo sapiens (human);Developmental Biology;Signaling by GPCR;Signal Transduction;Sema4D mediated inhibition of cell attachment and migration;Sema4D induced cell migration and growth-cone collapse;Sema4D in semaphorin signaling;Semaphorin interactions;Axon guidance;G alpha (12/13) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.119
Intolerance Scores
- loftool
- 0.481
- rvis_EVS
- -2.51
- rvis_percentile_EVS
- 0.93
Haploinsufficiency Scores
- pHI
- 0.158
- hipred
- Y
- hipred_score
- 0.747
- ghis
- 0.596
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.905
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Plxnb1
- Phenotype
- cellular phenotype; reproductive system phenotype; normal phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); renal/urinary system phenotype;
Zebrafish Information Network
- Gene name
- plxnb1b
- Affected structure
- CaP motoneuron
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- negative regulation of cell adhesion;signal transduction;G protein-coupled receptor signaling pathway;regulation of cell shape;positive regulation of phosphatidylinositol 3-kinase signaling;cell migration;regulation of cell migration;negative regulation of osteoblast proliferation;intracellular signal transduction;regulation of GTPase activity;positive regulation of GTPase activity;ossification involved in bone maturation;neuron projection morphogenesis;positive regulation of axonogenesis;regulation of cytoskeleton organization;semaphorin-plexin signaling pathway;semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis;semaphorin-plexin signaling pathway involved in axon guidance
- Cellular component
- semaphorin receptor complex;extracellular region;plasma membrane;integral component of plasma membrane
- Molecular function
- transmembrane signaling receptor activity;GTPase activator activity;protein binding;semaphorin receptor activity;semaphorin receptor binding;GTPase activating protein binding;signaling receptor activity